Search results
Results From The WOW.Com Content Network
Roche. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996.
Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Roche Holding AG (SWX:ROG) a safer option. Doing business globally, large caps tend to ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
At stake will be the weight-loss drugs market, which could become as large as $100 billion or more by the end of the decade. Roche's trailing-12-month revenue is $67.7 billion. While it won't be ...
Language links are at the top of the page across from the title.
Let's see if Roche Holding AG (RHHBY) stock is a good choice for value-oriented investors right now from multiple angles.
André Hoffmann (born 31 May 1958) is a Swiss billionaire businessman, environmentalist and philanthropist. The great-grandson of Fritz Hoffmann-La Roche who founded the drug company Roche Holding in 1896, [1] he currently is the vice-chairman of the company. [2] As of November 2020, his estimated net worth is US$5.71 billion [3]